These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prevention of hepatocellular carcinoma. Wands JR N Engl J Med; 2004 Oct; 351(15):1567-70. PubMed ID: 15470221 [No Abstract] [Full Text] [Related]
23. [Hepatitis B and the prevention of hepatocellular carcinoma]. Blumberg BS Nouv Presse Med; 1982 Mar; 11(12):903-5. PubMed ID: 6278399 [No Abstract] [Full Text] [Related]
24. Prevention of mortality from hepatitis B and hepatitis C. Schiff ER Lancet; 2006 Sep; 368(9539):896-7. PubMed ID: 16962862 [No Abstract] [Full Text] [Related]
26. Can primary cancer of the liver in Western countries be prevented? Pediatric point of view. Perilongo G; Pontisso P; Basso G Med Pediatr Oncol; 1990; 18(1):57-60. PubMed ID: 2152958 [No Abstract] [Full Text] [Related]
27. Trends of aetiological factors of hepatocellular carcinoma in Italy. Stroffolini T; Sagnelli E; Mele A; Almasio P Dig Liver Dis; 2005 Dec; 37(12):985-6. PubMed ID: 16169300 [No Abstract] [Full Text] [Related]
28. [Hepatitis B and hepatitis C, a high stake for public health: how to reconcile health cost control and public health expenses?]. Allerg Immunol (Paris); 1997 Sep; 29(7):215-8. PubMed ID: 9432191 [No Abstract] [Full Text] [Related]
29. Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. Lai CL; Yuen MF Hepatology; 2013 Jan; 57(1):399-408. PubMed ID: 22806323 [TBL] [Abstract][Full Text] [Related]
30. HBV infection and hepatocellular carcinoma. Iavarone M; Colombo M Clin Liver Dis; 2013 Aug; 17(3):375-97. PubMed ID: 23905811 [TBL] [Abstract][Full Text] [Related]
31. Report of the OAU/STRC Ad Hoc Committee on Hepatitis B Vaccination in Africa. IARC Sci Publ; 1984; (63):393-401. PubMed ID: 6100277 [No Abstract] [Full Text] [Related]
32. Does antiviral therapy prevent recurrence of hepatitis B virus–related hepatocellular carcinoma after curative liver resection? Lok AS JAMA; 2012 Nov; 308(18):1922-24. PubMed ID: 23147511 [No Abstract] [Full Text] [Related]
33. Antiviral therapy after curative resection for patients with hepatitis B-related hepatocellular carcinoma. Chong CC; Lai PB Br J Surg; 2013 May; 100(6):724-5. PubMed ID: 23475744 [No Abstract] [Full Text] [Related]
34. [Risk factors and prevention of hepatocellular carcinoma]. Tanaka K Fukuoka Igaku Zasshi; 1997 Oct; 88(10):325-30. PubMed ID: 9432489 [No Abstract] [Full Text] [Related]
35. Hepatocellular carcinoma. New directions in etiology. Maltz C; Lightdale CJ; Winawer SJ Am J Gastroenterol; 1980 Oct; 74(4):361-5. PubMed ID: 6161536 [No Abstract] [Full Text] [Related]
36. Prevention of Liver Fibrosis and Cancer in Africa: The PROLIFICA project--a collaborative study of hepatitis B-related liver disease in West Africa. Howell J; Ladep NG; Lemoine M; Nayagam S; Toure PS; Diop MM; Daveiga Joao Armindo ; Sall AS; Lo G; Crossey MM; Thursz MR; Taylor-Robinson SD; Ka MM S Afr Med J; 2015 Mar; 105(3):185-6. PubMed ID: 26294822 [No Abstract] [Full Text] [Related]
37. Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma. Bridges EG; Cheng YC Prog Liver Dis; 1995; 13():231-45. PubMed ID: 9224504 [No Abstract] [Full Text] [Related]
38. Prevention of hepatocellular carcinoma by immunization against hepatitis B. Zuckerman AJ Int Rev Exp Pathol; 1985; 27():59-81. PubMed ID: 3017884 [No Abstract] [Full Text] [Related]
39. [Prevention of hepatocellular carcinogenesis by interferon]. Ikeda K Nihon Rinsho; 2001 Oct; 59 Suppl 6():755-63. PubMed ID: 11762051 [No Abstract] [Full Text] [Related]